Author:
Torrents Sílvia,Grau-Vorster Marta,Vives Joaquim
Publisher
Springer International Publishing
Reference56 articles.
1. Agency EM (2017) ICH guideline Q8 (R2) on pharmaceutical development, London
2. Guideline IHT (1999) ICH topic Q6B. Note for guidance on specifications: test procedures and acceptance criteria for biotechnological/biological products. European Medicines Agency, London
3. Schneider CK, Salmikangas P, Jilma B, Flamion B, Todorova LR, Paphitou A et al (2010) Challenges with advanced therapy medicinal products and how to meet them. Nat Rev Drug Discov 9(3):195–201
4. Guadix JA, López-Beas J, Clares B, Soriano-Ruiz JL, Zugaza JL, Gálvez-Martín P (2019) Principal criteria for evaluating the quality, safety and efficacy of hMSC-based products in clinical practice: current approaches and challenges. Pharmaceutics 11(11):552
5. Fang Y, Eglen RM (2017) Three-dimensional cell cultures in drug discovery and development. SLAS Discov 22(5):456–472